BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18802118)

  • 21. The TCR repertoire of an immunodominant CD8+ T lymphocyte population.
    Chen ZW; Li Y; Zeng X; Kuroda MJ; Schmitz JE; Shen Y; Lai X; Shen L; Letvin NL
    J Immunol; 2001 Apr; 166(7):4525-33. PubMed ID: 11254709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.
    Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME
    AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other.
    Goulder PJ; Tang Y; Pelton SI; Walker BD
    J Virol; 2000 Jun; 74(11):5291-9. PubMed ID: 10799606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.
    Gillespie GM; Kaul R; Dong T; Yang HB; Rostron T; Bwayo JJ; Kiama P; Peto T; Plummer FA; McMichael AJ; Rowland-Jones SL
    AIDS; 2002 May; 16(7):961-72. PubMed ID: 11953462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
    Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
    J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes.
    Schaubert KL; Price DA; Salkowitz JR; Sewell AK; Sidney J; Asher TE; Blondelle SE; Adams S; Marincola FM; Joseph A; Sette A; Douek DC; Ayyavoo V; Storkus W; Leung MY; Ng HL; Yang OO; Goldstein H; Wilson DB; Kan-Mitchell J
    Eur J Immunol; 2010 Jul; 40(7):1950-62. PubMed ID: 20432235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
    Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
    AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
    Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire.
    Meyer-Olson D; Brady KW; Bartman MT; O'Sullivan KM; Simons BC; Conrad JA; Duncan CB; Lorey S; Siddique A; Draenert R; Addo M; Altfeld M; Rosenberg E; Allen TM; Walker BD; Kalams SA
    Blood; 2006 Mar; 107(6):2373-83. PubMed ID: 16322475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.
    Lichterfeld M; Williams KL; Mui SK; Shah SS; Mothe BR; Sette A; Kim A; Johnston MN; Burgett N; Frahm N; Cohen D; Brander C; Rosenberg ES; Walker BD; Altfeld M; Yu XG
    Int Immunol; 2006 Jul; 18(7):1179-88. PubMed ID: 16772368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
    Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
    J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biased TCR repertoire in HIV-1-infected patients due to clonal expansion of HIV-1-reverse transcriptase-specific CTL clones.
    Kolowos W; Schmitt M; Herrman M; Harrer E; Löw P; Kalden JR; Harrer T
    J Immunol; 1999 Jun; 162(12):7525-33. PubMed ID: 10358208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.
    Yu XG; Lichterfeld M; Chetty S; Williams KL; Mui SK; Miura T; Frahm N; Feeney ME; Tang Y; Pereyra F; Labute MX; Pfafferott K; Leslie A; Crawford H; Allgaier R; Hildebrand W; Kaslow R; Brander C; Allen TM; Rosenberg ES; Kiepiela P; Vajpayee M; Goepfert PA; Altfeld M; Goulder PJ; Walker BD
    J Virol; 2007 Feb; 81(4):1619-31. PubMed ID: 17121793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escape from highly effective public CD8+ T-cell clonotypes by HIV.
    Iglesias MC; Almeida JR; Fastenackels S; van Bockel DJ; Hashimoto M; Venturi V; Gostick E; Urrutia A; Wooldridge L; Clement M; Gras S; Wilmann PG; Autran B; Moris A; Rossjohn J; Davenport MP; Takiguchi M; Brander C; Douek DC; Kelleher AD; Price DA; Appay V
    Blood; 2011 Aug; 118(8):2138-49. PubMed ID: 21734237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public TCR use by herpes simplex virus-2-specific human CD8 CTLs.
    Dong L; Li P; Oenema T; McClurkan CL; Koelle DM
    J Immunol; 2010 Mar; 184(6):3063-71. PubMed ID: 20139278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes.
    Buseyne F; Rivière Y
    Int Immunol; 2001 Jul; 13(7):941-50. PubMed ID: 11431424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.
    Silins SL; Cross SM; Krauer KG; Moss DJ; Schmidt CW; Misko IS
    J Clin Invest; 1998 Oct; 102(8):1551-8. PubMed ID: 9788968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.
    Turnbull EL; Lopes AR; Jones NA; Cornforth D; Newton P; Aldam D; Pellegrino P; Turner J; Williams I; Wilson CM; Goepfert PA; Maini MK; Borrow P
    J Immunol; 2006 May; 176(10):6130-46. PubMed ID: 16670322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response.
    Annels NE; Callan MF; Tan L; Rickinson AB
    J Immunol; 2000 Nov; 165(9):4831-41. PubMed ID: 11046006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonotype tracking of TCR repertoires during chronic virus infections.
    Cohen GB; Islam SA; Noble MS; Lau C; Brander C; Altfeld MA; Rosenberg ES; Schmitz JE; Cameron TO; Kalams SA
    Virology; 2002 Dec; 304(2):474-84. PubMed ID: 12504586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.